{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:40:01Z","timestamp":1790664001160,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ijcard.2022.08.018","type":"journal-article","created":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T19:09:54Z","timestamp":1659812994000},"page":"54-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Serum glypican-4 is associated with the 10-year clinical outcome of patients with peripheral artery disease"],"prefix":"10.1016","volume":"369","author":[{"given":"Axel","family":"Muendlein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Heinzle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Leiherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Geiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Maria","family":"Brandtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Gaenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Fraunberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph H.","family":"Saely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Drexel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2022.08.018_bb0005","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002407","article-title":"Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease","volume":"9","author":"Sprenger","year":"2021","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"10.1016\/j.ijcard.2022.08.018_bb0010","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.jacc.2007.11.077","article-title":"Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease","volume":"51","author":"Welten","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0015","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM199202063260605","article-title":"Mortality over a period of 10 years in patients with peripheral arterial disease","volume":"326","author":"Criqui","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0020","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1161\/ATVBAHA.120.314774","article-title":"Plasma biomarkers to predict cardiovascular outcome in patients with peripheral artery disease: a systematic review and Meta-analysis","volume":"40","author":"Kremers","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0025","article-title":"Data on the association of serum glypican-4 with future major adverse cardiovascular events and mortality in patients undergoing coronary angiography","volume":"42","author":"Muendlein","year":"2022","journal-title":"Data Br."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.atherosclerosis.2022.02.015","article-title":"Serum glypican-4 is a marker of future vascular risk and mortality in coronary angiography patients","volume":"345","author":"Muendlein","year":"2022","journal-title":"Atherosclerosis."},{"issue":"2007","key":"10.1016\/j.ijcard.2022.08.018_bb0035","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00424-007-0212-8","article-title":"The endothelial glycocalyx: composition, functions, and visualization","volume":"454","author":"Reitsma","year":"2007","journal-title":"Pflugers Arch. - Eur. J. Physiol."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0040","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1242\/dev.113894","article-title":"Glypican4 promotes cardiac specification and differentiation by attenuating canonical Wnt and bmp signaling","volume":"142","author":"Strate","year":"2015","journal-title":"Dev."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0045","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/dvdy.10298","article-title":"Localisation of specific heparan sulfate proteoglycans during the proliferative phase of brain development","volume":"227","author":"Ford-Perriss","year":"2003","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0050","doi-asserted-by":"crossref","first-page":"8745","DOI":"10.1128\/MCB.24.19.8745-8752.2004","article-title":"Hepatocyte growth factor-mediated renal epithelial branching morphogenesis is regulated by Glypican-4 expression","volume":"24","author":"Karihaloo","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0055","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2337\/db11-1395","article-title":"Glypican-4 enhances insulin signaling via interaction with the insulin receptor and serves as a novel adipokine","volume":"61","author":"Ussar","year":"2012","journal-title":"Diabetes."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0060","article-title":"Heparan sulfated Glypican-4 is released from astrocytes predominantly by proteolytic shedding","author":"Huang","year":"2021","journal-title":"BioRxiv."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0065","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1042\/BJ20070511","article-title":"Mammalian notum induces the release of glypicans and other GPI-anchored proteins from the cell surface","volume":"410","author":"Traister","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0070","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1055\/s-0041-1725063","article-title":"Circulating Heparan sulfate proteoglycans as biomarkers in health and disease","volume":"47","author":"Lepedda","year":"2021","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0075","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3904\/kjim.2016.114","article-title":"Long-term study of the association of adipokines and glucose variability with diabetic complications","volume":"33","author":"Cha","year":"2018","journal-title":"Korean J. Intern. Med."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0080","doi-asserted-by":"crossref","first-page":"E2697","DOI":"10.1210\/jc.2014-2018","article-title":"The changes of serum glypican4 in obese patients with different glucose metabolism status","volume":"99","author":"Zhu","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0085","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s40618-020-01372-9","article-title":"Serum glypican4 and glycosylphosphatidylinositol-specific phospholipase D levels are associated with adipose tissue insulin resistance in obese subjects with different glucose metabolism status","volume":"44","author":"Zhang","year":"2021","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0090","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1210\/jc.2012-4297","article-title":"Association of glypican-4 with body fat distribution, insulin resistance, and nonalcoholic fatty liver disease","volume":"98","author":"Yoo","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0095","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00592-014-0652-5","article-title":"Glypican-4 is increased in human subjects with impaired glucose tolerance and decreased in patients with newly diagnosed type 2 diabetes","volume":"51","author":"Li","year":"2014","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0100","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/cen.13435","article-title":"Serum glypican 4 level in obese children and its relation to degree of obesity","volume":"87","author":"Leelalertlauw","year":"2017","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0105","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3803\/EnM.2016.31.3.439","article-title":"Correlation of glypican-4 level with basal active glucagon-like peptide 1 level in patients with type 2 diabetes mellitus","volume":"31","author":"Lee","year":"2016","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107692","article-title":"Type 2 diabetes mellitus is a strong predictor of LDL cholesterol target achievement in patients with peripheral artery disease","volume":"34","author":"Saely","year":"2020","journal-title":"J. Diabetes Complicat."},{"issue":"2013","key":"10.1016\/j.ijcard.2022.08.018_bb0115","first-page":"2159","article-title":"ESH\/ESC guidelines for the management of arterial hypertension: the task force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0120","first-page":"S1","article-title":"Standards of medical care in diabetes-2015","volume":"38","author":"American Diabetes Association","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2022.08.018_bb0125","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","year":"2002","journal-title":"Circulation"},{"issue":"2018","key":"10.1016\/j.ijcard.2022.08.018_bb0130","first-page":"763","volume":"39","author":"Aboyans","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0135","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/1568006043335989","article-title":"Critical limb ischemia: definition and natural history","volume":"4","author":"Novo","year":"2004","journal-title":"Curr. Drug Targets. Cardiovasc. Haematol. Disord."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0140","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0145","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/EJE-17-0883","article-title":"METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes","volume":"178","author":"Bello-Chavolla","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0155","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0165","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/joim.13368","article-title":"Lipid profiles of patients with manifest coronary versus peripheral atherosclerosis - is there a difference?","volume":"290","author":"Leiherer","year":"2021","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0170","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.atherosclerosis.2015.01.021","article-title":"Systemic inflammation is higher in peripheral artery disease than in stable coronary artery disease","volume":"239","author":"Rein","year":"2015","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0175","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1161\/01.CIR.0000137913.26087.F0","article-title":"Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000","volume":"110","author":"Selvin","year":"2004","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0180","first-page":"R508","article-title":"The glycocalyx: a central regulator of vascular function","volume":"320","author":"Moore","year":"2021","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0185","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.coph.2019.04.011","article-title":"The role of the endothelial glycocalyx in advanced age and cardiovascular disease","volume":"45","author":"Machin","year":"2019","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0190","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11897-017-0320-5","article-title":"Endothelial glycocalyx as biomarker for cardiovascular diseases: mechanistic and clinical implications","volume":"14","author":"Kim","year":"2017","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0195","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1055\/s-0041-1725063","article-title":"Circulating Heparan sulfate proteoglycans as biomarkers in health and disease","volume":"47","author":"Lepedda","year":"2021","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0200","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/aas.13797","article-title":"Human glycocalyx shedding: systematic review and critical appraisal","volume":"65","author":"Hahn","year":"2021","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0205","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/01.CIR.101.13.1500","article-title":"Oxidized lipoproteins degrade the endothelial surface layer: implications for platelet-endothelial cell adhesion","volume":"101","author":"Vink","year":"2000","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0210","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/jch.14002","article-title":"Sex-related associations of high-density lipoprotein cholesterol with aortic stiffness and endothelial glycocalyx integrity in treated hypertensive patients","volume":"22","author":"Triantafyllidi","year":"2020","journal-title":"J. Clin. Hypertens. (Greenwich)."},{"key":"10.1016\/j.ijcard.2022.08.018_bb0215","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.atherosclerosis.2017.05.012","article-title":"Effects of varenicline and nicotine replacement therapy on arterial elasticity, endothelial glycocalyx and oxidative stress during a 3-month smoking cessation program","volume":"262","author":"Ikonomidis","year":"2017","journal-title":"Atherosclerosis."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527322011858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527322011858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:58:19Z","timestamp":1759093099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527322011858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":43,"alternative-id":["S0167527322011858"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2022.08.018","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum glypican-4 is associated with the 10-year clinical outcome of patients with peripheral artery disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2022.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}